Inhibition of cyclooxygenase-2 promotes the stimulatory action of adenosine A 3 receptor agonist on hematopoiesis in sublethally γ-irradiated mice

Biomedicine and Pharmacotherapy

Volumn 65, Issue 6, 2011, Pages 427-431

  Hofer, Michal ^a   Pospíšil, Milan ^a   Dušek, Ladislav ^b   Hoferová, Zuzana ^a   Weiterová, Lenka ^a  

^a INSTITUTE OF BIOPHYSICS   (Czech Republic)

^b MASARYK UNIVERSITY   (Czech Republic)

Author keywords

Adenosine A 3 receptor agonist; COX 2 inhibitor; Hematopoiesis

Indexed keywords

6 N (3 IODOBENZYL)ADENOSINE 5' N METHYLCARBOXAMIDE; ADENOSINE A3 RECEPTOR AGONIST; CYCLOOXYGENASE 2; MELOXICAM;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME INHIBITION; ERYTHROCYTE; GAMMA IRRADIATION; GRANULOCYTE; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; IONIZING RADIATION; MACROPHAGE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SINGLE DRUG DOSE; STIMULATION;

ADENOSINE; ADENOSINE A3 RECEPTOR AGONISTS; ANIMALS; CELL COUNT; CROSSES, GENETIC; CYCLOOXYGENASE 2 INHIBITORS; DRUG THERAPY, COMBINATION; ERYTHROID PRECURSOR CELLS; GAMMA RAYS; GRANULOCYTE COLONY-STIMULATING FACTOR; GRANULOCYTE PRECURSOR CELLS; HEMATINICS; HEMATOPOIESIS; HEMATOPOIETIC STEM CELLS; MALE; MICE; MICE, INBRED CBA; RADIATION INJURIES, EXPERIMENTAL; THIAZINES; THIAZOLES; WHOLE-BODY IRRADIATION;

EID: 80052662992     PISSN: 07533322     EISSN: 19506007     Source Type: Journal    
DOI: 10.1016/j.biopha.2011.04.033     Document Type: Article

References (29)

1. Weiss J.F., Kumar K.S., Walden T.L., Neta R., Landauer M.R., Clark E.P. Advances in radioprotection through the use of combined agent regimens. Int J Radiat Biol 1990, 57:709-722.
2. Pospíšil M., Hofer M., Znojil V., Vácha J., Netíková J., Holá J. Synergistic effects of granulocyte colony-stimulating factor and drugs elevating extracellular adenosine on neutrophil production in mice. Blood 1995, 86:3692-3697.
3. Hérodin F., Bourin P., Mayol J.F., Lataillade J.J., Drouet M. Short-term injection of antiapoptotic cytokine combinations soon after lethal γ-irradiation promotes survival. Blood 2003, 101:2609-2616.
4. Hérodin F., Drouet M. Cytokine-based treatment of accidentally irradiated victims and new approaches. Exp Hematol 2005, 33:1071-1080.
5. Hofer M., Pospíšil M. Role of adenosine signaling in hematopoiesis - a short review. Med Hypotheses Res 2006, 3:629-635.
6. Hofer M., Pospíšil M. Stimulated recovery of perturbed haematopoiesis by inhibition of prostaglandin production - promising therapeutic strategy. Cent Eur J Biol 2006, 1:584-593.
7. Kurland J., Moore M.A.S. Modulation of hemopoiesis by prostaglandins. Exp Hematol 1977, 5:357-373.
8. Fontagné J., Adolphe M., Semichon M., Zizine L., Lechat P. Effect of in vivo treatment with indomethacin on mouse granulocyte-macrophage colony-forming cells in culture (CFUc). Possible role of prostaglandins. Exp Hematol 1980, 8:1157-1164.
9. Pelus L.M. Modulation of myelopoiesis by prostaglandin E2: demonstration of novel mechanism of action in vivo. Immunol Res 1989, 8:176-184.
10. Frölich J.C. A classification of NSAIDs according to the relative inhibition of cyclooxygenase isoenzymes. Trends Pharmacol Sci 1997, 18:30-34.
11. Akarca U.S. Gastrointestinal effects of selective and non-selective non-steroidal anti-inflammatory drugs. Curr Pharm Des 2005, 11:1779-1793.
12. Lanas A., Panés J., Piqué J.M. Clinical implications of COX-1 and/or COX-2 inhibtion for the distal gastrointestinal tract. Curr Pharm Des 2003, 9:2253-2566.
13. Hofer M., Pospíšil M., Znojil V., Holá J., Vacek A., Weiterová L., et al. Meloxicam, a cyclooxygenase 2 inhibitor, supports hematopoietic recovery in gamma-irradiated mice. Radiat Res 2006, 166:556-560.
14. Hofer M., Pospíšil M., Holá J., Vacek A., Štreitová D., Znojil V. Inhibition of cyclooxygenase 2 in mice increases production of G-CSF and induces radioprotection. Radiat Res 2008, 170:566-571.
15. Jacobson M.A. Adenosine receptor agonists. Exp Opin Ther Targets 2002, 12:489-501.
16. Abbracchio M.P., Burnstock G. Purinergic signalling: pathophysiological roles. Jpn J Pharmacol 1998, 78:113-145.
17. Poulsen S.A., Quinn R.J. Adenosine receptors: new opportunities for future drugs. Bioorg Med Chem 1998, 6:619-641.
18. Hofer M., Pospíšil M., Znojil V., Vacek A., Weiterová L., Holá J., et al. Drugs elevating extracellular adenosine promote regeneration of haematopoietic progenitor cells in severely myelosuppressed mice. Their comparison and joint effects with the granulocyte colony-stimulating factor. Eur J Haematol 2002, 68:4-11.
19. Bar-Yehuda S., Madi L., Barak D., Mittelman M., Ardon E., Ochaion A., et al. Agonists to the A3 adenosine receptor induce G-CSF production via NF-kappa B activation: a new class of myeloprotective agents. Exp Hematol 2002, 30:1390-1398.
20. Pospíšil M., Hofer M., Vacek A., Znojil V., Pipalová I. Effects of stable adenosine receptor agonists on bone marrow hematopoietic cells as inferred from the cytotoxic action of 5-fluorouracil. Physiol Res 2004, 53:549-556.
21. Hofer M., Pospíšil M., Vacek A., Holá J., Znojil V., Weiterová L., et al. Effects of adenosine A3 receptor agonist on bone marrow granulocytic system in 5-fluorouracil-treated mice. Eur J Pharmacol 2006, 538:163-167.
22. Hofer M., Pospíšil M., Znojil V., Holá J., Vacek A., Štreitová D. Adenosine A3 receptor agonist acts as a homeostatic regulator of bone marrow hematopoiesis. Biomed Pharmacother 2007, 61:356-359.
23. Hofer M., Pospíšil M., Znojil V., Holá J., Štreitová D., Vacek A. Homeostatic action of adenosine A3 and A1 receptor agonists on proliferation of hematopoietic precursor cells. Exp Biol Med 2008, 233:897-900.
24. Hofer M., Pospíšil M., Znojil V., Holá J., Vacek A., Štreitová D. Meloxicam, an inhibitor of cyclooxygenase-2, increases the level of serum G-CSF and might be usable as an auxiliary means in G-CSF therapy. Physiol Res 2008, 57:307-310.
25. Hofer M., Pospíšil M., Šefc L., Dušek L., Vacek A., Holá J., et al. Activation of adenosine A3 receptors supports hematopoiesis-stimulating effects of granulocyte colony-stimulating factor. Int J Radiat Biol 2010, 86:649-656.
26. Richards M.K., Liu F.L., Iwasaki H., Akashi K., Link D.C. Pivotal role of granulocyte colony-stimulating factor in the development of progenitors in the common myeloid pathway. Blood 2003, 102:3562-3568.
27. Metcalf D. Hematopoietic regulators: redundancy or subtlety?. Blood 1993, 82:3515-3523.
28. Williams G.T., Smith C.A., Spooncer E., Dexter T.M., Taylor D.R. Haemopoietic colony stimulating factors promote cell survival by suppressing apoptosis. Nature 1990, 343:76-79.
29. Moulder J.E. Post-irradiation approaches to treatment of radiation injuries in the context of radiological terrorism and radiation accidents: a review. Int J Radiat Biol 2004, 80:3-10.